ArticlePharmaceuticals (Basel, Switzerland)2024

Targeting MutT Homolog 1 (MTH1) for Breast Cancer Suppression by Using a Novel MTH1 Inhibitor MA-24 with Tumor-Selective Toxicity.

Nannan Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.